Cargando…

Single-pill combinations: a therapeutic option or necessity for vascular risk treatment?

Detalles Bibliográficos
Autores principales:	Katsiki, Niki, Athyros, Vasilios G., Karagiannis, Asterios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Maney Publishing 2013
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4937652/ https://www.ncbi.nlm.nih.gov/pubmed/27536439 http://dx.doi.org/10.3109/21556660.2013.801605

Ejemplares similares

Preventing Cardio-renal Syndrome Rather than Treating It: Could Statins Play A Role?
por: Athyros, Vasilios G, et al.
Publicado: (2011)

Off target effects of statins shape total mortality?
por: Athyros, Vasilios G., et al.
Publicado: (2016)

The clinical benefit of implementing guidelines in cardiovascular disease prevention in real world settings
por: Athyros, Vasilios G., et al.
Publicado: (2012)

Differential residual dyslipidemia/cardiovascular risk after statin treatment between Asian-Indians and western whites. Call for action
por: Athyros, Vasilios Gabriel, et al.
Publicado: (2016)

Are we getting to lipid targets in real life?
por: Katsiki, Niki, et al.
Publicado: (2010)

Dyslipidemia Induced by Drugs Used for the Prevention and Treatment of Vascular Diseases
por: Tziomalos, Konstantinos, et al.
Publicado: (2011)

Is There a Role for Hypolipidaemic Drug Therapy in the Prevention or Treatment of Microvascular Complications of Diabetes?
por: Mitsiou, Eydoxia K, et al.
Publicado: (2012)

Is There an Association Between Carotid-Femoral Pulse Wave Velocity and Coronary Heart Disease in Patients with Coronary Artery Disease: A Pilot Study
por: Katsiki, Niki, et al.
Publicado: (2016)

Dyslipidaemia of Obesity, Metabolic Syndrome and Type 2 Diabetes Mellitus: the Case for Residual Risk Reduction After Statin Treatment
por: Athyros, Vasilios G, et al.
Publicado: (2011)

IMproving the imPlemEntation of cuRrent guidelines for the mAnagement of major coronary hearT disease rIsk factors by multifactorial interVEntion. The IMPERATIVE renal analysis
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Statins and cardiovascular outcomes in elderly and younger patients with coronary artery disease: a post hoc analysis of the GREACE study
por: Athyros, Vasilios G., et al.
Publicado: (2013)

Is there an additional benefit from coronary revascularization in diabetic patients with acute coronary syndromes or stable angina who are already on optimal medical treatment?
por: Athyros, Vasilios G., et al.
Publicado: (2011)

Improving vascular health: are pills the answer?
por: Smeeth, Liam, et al.
Publicado: (2012)

Comparative Effect of Atorvastatin and Rosuvastatin on 25-hydroxy-Vitamin D Levels in Non-diabetic Patients with Dyslipidaemia: A Prospective Randomized Open-label Pilot Study
por: Anagnostis, Panagiotis, et al.
Publicado: (2014)

Arterial stiffness correlates with progressive nailfold capillary microscopic changes in systemic sclerosis: results from a cross-sectional study
por: Soulaidopoulos, Stergios, et al.
Publicado: (2019)

Additivity of nebivolol/valsartan single‐pill combinations versus other single‐pill combinations for hypertension
por: Ishak, Jack, et al.
Publicado: (2017)

Statin-Induced Increase in HDL-C and Renal Function in Coronary Heart Disease Patients(§)
por: Athyros, Vasilios G, et al.
Publicado: (2007)

Is it Time for Single-Pill Combinations in Dyslipidemia?
por: Schiele, François, et al.
Publicado: (2021)

Tofacitinib as a Promising Therapeutic Option in Refractory Autoimmune-Mediated Vascular and Sclera Inflammation
por: Dimitroulas, Theodoros
Publicado: (2023)

Fenofibrate: a novel formulation (Triglide™) in the treatment of lipid disorders: a review
por: Tziomalos, Konstantinos, et al.
Publicado: (2006)

Research in orthopedics: A necessity
por: Jain, Anil K
Publicado: (2009)

Genome and metabolome: chance and necessity
por: Gonçalves, Emanuel, et al.
Publicado: (2021)

The Necessity for a Higher Standard
Publicado: (1888)

Is the Combination of ICS and LABA, a Therapeutic Option for COPD, Fading Away?
por: Oh, Yeon-Mok
Publicado: (2017)

A Bitter Pill
Publicado: (1891)

Therapeutic Treatments for Osteoporosis—Which Combination of Pills Is the Best among the Bad?
por: Tonk, Christian Horst, et al.
Publicado: (2022)

Leveraging MYC as a therapeutic treatment option for TNBC
por: Carey, Jason P.W., et al.
Publicado: (2018)

What is ‘medical necessity’?
por: Wilkinson, Dominic JC
Publicado: (2023)

Epicardial fat: a novel marker of subclinical atherosclerosis in clinical practice?
por: Katsiki, Niki, et al.
Publicado: (2017)

Necessity for a National Trauma Center
por: Ebrahimi, Ali
Publicado: (2014)

Necessity for a Uniform Degree or Title
Publicado: (1895)

The Necessity of Checking the Status and Performance of Methadone Maintenance Treatment Centers in Iran
por: Mohebi, Mohammad Davood
Publicado: (2013)

The challenges and necessity of situating ‘illness narratives’ in recovery and mental health treatment
por: Khan, Nagina, et al.
Publicado: (2022)

Adherence to Lipid-Lowering Treatment by Single-Pill Combination of Statin and Ezetimibe
por: Rea, Federico, et al.
Publicado: (2021)

Single-Pill Combination to Improve Hypertension Treatment: Pharmaceutical Industry Development
por: Paczkowska-Walendowska, Magdalena, et al.
Publicado: (2022)

Initial Single‐Pill Blood Pressure–Lowering Therapy: Should It Be for Most People?
por: Al Dhabyi, Omar, et al.
Publicado: (2017)

Upjohn Pill and Granule Co.
Publicado: (1889)

Dr. Ghent’s Hepatic Pills
Publicado: (1890)

Warner’s Sugar-Coated Pills
Publicado: (1881)

Reduction of Vascular Inflammation, LDL-C, or Both for the Protection from Cardiovascular Events?
por: Reklou, Andromachi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_nsrcie4vi0g9che257ntt3dlln